New Documentary Released by Medtronic: "A Voice for Health"
Join us on a journey to Kenya and discover how Medtronic LABS is expanding access to essential healthcare.
NORTHAMPTON, MA / ACCESSWIRE / April 8, 2024 / Yesterday was World Health Day, and the theme this year is ‘My health, my right'. Over half the world's population can't access essential health services. The mission of Medtronic LABS is to change that. Watch as the team travels to Kenya to capture the everyday stories from people who utilize LABS' technology to better track their health.
Today we published a short documentary, "A voice for health", that follows Jane, a patient engagement lead for Medtronic LABS in Kenya, as she works with community partners to bring this mission to life.
You can watch the documentary here, and learn more about LABS' work here.
View additional multimedia and more ESG storytelling from Medtronic on 3blmedia.com.
Contact Info:
Spokesperson: Medtronic
Website: https://www.3blmedia.com/profiles/medtronic
Email: info@3blmedia.com
SOURCE: Medtronic
View the original press release on accesswire.com
-
Why Immigration Has Boosted Job Gains and the Economy
-
What to Invest in During High Inflation
-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
Markets Brief: All Eyes On Inflation
-
5 Things We Learned From the Q1 Earnings Season
-
After Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Target Stock a Buy, a Sell, or Fairly Valued?
-
Walmart Earnings: Low Prices and Strong Digital Presence Drive Market Share Gains
-
After Earnings and a Big Selloff, Is Shopify Stock a Buy, a Sell, or Fairly Valued?
-
Cisco Earnings: Positive Guidance and Splunk Inclusion Align With Our Long-Term Thesis
-
3 Warren Buffett Stocks to Buy After Berkshire Hathaway’s Just-Released 13F Filing
-
Going Into Earnings, Is Nvidia Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is Arista Stock a Buy, a Sell, or Fairly Valued?
-
A Cheap Dividend Aristocrat to Buy Before It Bounces Back